{"id":"W2479909615","doi":"10.14785/lymphosign-2016-0004","title":"Efficacy, safety, and tolerability of Kedrion 10% IVIG in primary immunodeficiency","year":2016,"lang":"en","type":"article","venue":"LymphoSign Journal","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hospital for Sick Children; Brampton Civic Hospital","funders":"","keywords":"Tolerability; Medicine; Primary immunodeficiency; Adverse effect; Pharmacokinetics; Off-label use; Clinical endpoint; Discontinuation; Pediatrics; Internal medicine; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009631724,0.0002766304,0.0004482583,0.0001032839,0.000102456,0.0003098793,0.0002312827,0.0002697365,0.0005635145],"category_scores_gemma":[0.0009897947,0.0001383777,0.0002366899,0.00008879393,0.0002600213,0.0001845919,0.0001193418,0.0005701201,0.0001285237],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002733748,"about_ca_system_score_gemma":0.0002319278,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003916032,"about_ca_topic_score_gemma":0.0003842437,"domain_scores_codex":[0.9996856,0.0001465989,0.00003006479,0.00003930818,0.00005656929,0.00004186381],"domain_scores_gemma":[0.999317,0.0002235097,0.0002671216,0.00003711013,0.00003655745,0.0001186264],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.2338143,0.01935683,0.2136449,0.001132852,0.0009736338,0.001770723,0.0009994771,0.006168841,0.2038813,0.0002224224,0.001640388,0.3163943],"study_design_scores_gemma":[0.02107324,0.6229391,0.3241571,0.00008741656,0.0005577171,0.00300916,0.0001551092,0.003267089,0.02280174,0.00007518034,0.001844775,0.00003249836],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9990296,0.0006656977,0.00009175691,0.00001321639,0.000002541492,0.00002619595,0.00001992542,0.000006435199,0.0001446187],"genre_scores_gemma":[0.999513,0.0002093746,0.0001220542,0.00002300423,0.000006042862,0.00001595578,0.00004939084,0.000001082907,0.00006003134],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0009631724,"threshold_uncertainty_score":0.005093753,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.006136023571688539,"score_gpt":0.2049729752206945,"score_spread":0.198836951649006,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}